10.1016/j.neuint.2015.06.003 51 WestermannB
Effects of fecal microbiota transplantation with oral capsules in obese patients
By recognizing patients who carry variants that put them at greater risk of experiencing adverse side effects, healthcare providers can tailor treatments to enhance effectiveness while minimizing potential toxicities
8,9,30 The agents used in these trials, including higher-dose semaglutide (2.4 mg) and the dual GLP-1/GIP receptor agonist tirzepatide, have demonstrated compelling benefits
Psychoneuroendocrinology 109:104400 Turkheimer FE, Selvaggi P, Mehta MA, Veronese M, Zelaya F, Dazzan P, Vernon AC (2020) Normalizing the abnormal: do antipsychotic drugs push the cortex into an unsustainable metabolic envelope